European Primary Care Cardiovascular Society

Debate: should we treat lifetime risk or 10-year risk?

3' education - Nov. 25, 2014 - Brussels, Belgium - Prof R. Hobbs, Th. Christiaens, C.Brotons & A. Hoes - EPCCS 2014

Prof. Richard Hobbs summarises the debate and how it affected the votes of the audience. Dr. Thierry Christiaens and Prof. Arno Hoes here repeat their arguments on why they think we should treat 10-year risk and lifetime risk respectively, and dr. Carlos Brotons makes a case for use of a polypill for those of 55 years and older.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: